55KRC: Grants aid UC research of pediatric brain tumors
Diffuse midline gliomas, formerly referred to as Diffuse Intrinsic Pontine Gliomas (DIPG), are deadly brain tumors. Each year, approximately 200-300 children in the United States are diagnosed with this tumor that is commonly located in the brain stem.
Timothy Phoenix, PhD, assistant professor in the University of Cincinnati's James L. Winkle College of Pharmacy Division of Pharmaceutical Sciences and a UC Cancer Center member, has recently received three separate grants studying how certain genetic factors affect the tumor's growth.
"We’ve learned a lot about what’s going wrong with these tumors in terms of genetic mutations," Phoenix told 55KRC's Simply Medicine program. "As we figure out what’s altered in these tumors, we can figure out drugs that might target these specific mutations."
Listen to the Simply Medicine segment. (Note: Segment begins around 12:30 mark.)
Read more about Phoenix's research.
Featured photo at top of Dr. Phoenix: Photo/Colleen Kelley/UC Creative + Brand
Related Stories
UC hires Dr. Gregory Postel as senior vice president of health...
April 23, 2024
UC Board of Trustees vote to hire Dr. Gregory Postel as senior vice president of health affairs and dean of UC College of Medicine.
UC pioneers green innovation with award-winning sustainability...
April 22, 2024
In the heart of April, as Earth Day blooms, the University of Cincinnati's Sustainability and Utilities Departments took center stage, orchestrating a symphony of eco-conscious activities to boost campus consciousness towards greener living. From vibrant campus Spring Fling festivities to enlightening tours of UC's acclaimed Utilities Plant and Civic Garden, the university community was treated to a variety of events aimed at fostering sustainable behaviors.
WVXU: Find your CPAP annoying? UC researchers are working on a...
April 22, 2024
Dr. Liran Oren is leading a research team at the University of Cincinnati developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.